A pivotal trial of MT-3724 (Monotherapy) in pateints with relapsed and refractory Diffuse-large-B-cell-lymphoma (Diffuse-large-B-cell-lymphoma)
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2017
At a glance
- Drugs MT 3724 (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Molecular Templates
- 24 Oct 2017 According to a Molecular Templates media release, this trial is expected to begin in 2018.
- 30 Mar 2017 According to a Molecular Templates media release, the company expects to initiate this trial before the end of 2017.
- 25 Mar 2017 New trial record